2012
DOI: 10.1016/j.talanta.2012.01.051
|View full text |Cite
|
Sign up to set email alerts
|

Multiplexed detection of tumor markers with multicolor quantum dots based on fluorescence polarization immunoassay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
50
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 108 publications
(50 citation statements)
references
References 38 publications
0
50
0
Order By: Relevance
“…Various approaches have been proposed to perform simultaneous detection of multiple tumor markers in the past few years. For example, electrochemical immunoassay (Wilson, 2007;Xu et al, 2014), label-free methods (Lin et al, 2011;Kong et al, 2013), dielectrophoresi assays (Lee et al, 2010;Ramón-Azcón et al, 2011), chemiluminescence alalysis (Zong et al, 2012;Guo et al, 2013), biobarcoded Scanometric assay (Stoeva et al, 2006), spectrometry (Chon et al, 2011;Giesen et al, 2011), fluorescence detection (Tian et al, 2012;Akinfieva et al, 2013), photonic suspension array (Zhao et al, 2009). But all these techniques are not suitable for point-of-care testing because they require large and sophisticated instruments, complex operations, long analysis time and highly skilled personnel to manipulate.…”
Section: Introductionmentioning
confidence: 99%
“…Various approaches have been proposed to perform simultaneous detection of multiple tumor markers in the past few years. For example, electrochemical immunoassay (Wilson, 2007;Xu et al, 2014), label-free methods (Lin et al, 2011;Kong et al, 2013), dielectrophoresi assays (Lee et al, 2010;Ramón-Azcón et al, 2011), chemiluminescence alalysis (Zong et al, 2012;Guo et al, 2013), biobarcoded Scanometric assay (Stoeva et al, 2006), spectrometry (Chon et al, 2011;Giesen et al, 2011), fluorescence detection (Tian et al, 2012;Akinfieva et al, 2013), photonic suspension array (Zhao et al, 2009). But all these techniques are not suitable for point-of-care testing because they require large and sophisticated instruments, complex operations, long analysis time and highly skilled personnel to manipulate.…”
Section: Introductionmentioning
confidence: 99%
“…Heterogeneous assays typically require analyte immobilization, multiple washing steps, and the physical separation of target bound complexes from non-target species prior to detection (Tachi et al, 2009;Tian et al, 2012). Traditionally, lateral flow assays (LFAs) and enzyme-linked immunosorbent assays (ELISAs) have been most commonly used to detect biomarkers in the human sera, urine, tears and food products (Kiening et al, 2005;Van Coillie et al, 2004;Wen et al, 2005aWen et al, , 2005b.…”
Section: Introductionmentioning
confidence: 99%
“…To overcome these drawbacks fluorescence polarization immunoassays (FPIAs) have been increasingly used for biomarker detection (Tachi et al, 2009;Tian et al, 2012;Wang et al, 2011;Xu et al, 2011). FPIAs are homogeneous immunoassays, rapid and simple to implement and do not require antibody immobilization or washing steps.…”
Section: Introductionmentioning
confidence: 99%
“…Traditional immunoassay methods for tumor markers include fluorescence, 11,12 spectroscopy, 13,14 chemiluminescence, 15,16 radioimmunoassay, 17,18 electrophoresis, 19 polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA). [20][21][22] Current methods can obtain accurate and reliable detection results but usually require expensive instruments and complex operating procedures.…”
mentioning
confidence: 99%